The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.

[1]  A. Esterman,et al.  How Effective Is Penetrating Corneal Transplantation? Factors Influencing Long-Term Outcome in Multivariate Analysis , 2006, Transplantation.

[2]  D. E. Zirm.  Eine erfolgreiche totale Keratoplastik , 1906, Albrecht von Graefes Archiv für Ophthalmologie.

[3]  Sanjay V. Patel,et al.  Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty. , 2005, Transactions of the American Ophthalmological Society.

[4]  R. Wolfe.  Long‐term Renal Allograft Survival: A Cup Both Half‐Full and Half‐Empty , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  C. Jessup,et al.  Gene therapy approaches to prolonging corneal allograft survival , 2004, Expert opinion on biological therapy.

[6]  P. McMenamin,et al.  The Distribution of Antigen in Lymphoid Tissues following Its Injection into the Anterior Chamber of the Rat Eye1 , 2004, The Journal of Immunology.

[7]  Jingtai Cao,et al.  VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. , 2004, The Journal of clinical investigation.

[8]  L. Missotten,et al.  Morphologic and immunophenotypic heterogeneity of corneal dendritic cells , 1991, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  A. Dick,et al.  Development of organised conjunctival leucocyte aggregates after corneal transplantation in rats , 2003, The British journal of ophthalmology.

[10]  J. Schold,et al.  Overview of Large Database Analysis in Renal Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  W. Hopfenmüller,et al.  HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

[12]  J. Streilein.  Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation , 2003, Journal of leukocyte biology.

[13]  M. Sykes,et al.  Mechanisms of transplant tolerance induction using costimulatory blockade. , 2002, Current opinion in immunology.

[14]  U. Rehany,et al.  The conundrum of death, dying and organ donation , 2002, The British journal of ophthalmology.

[15]  B. Delbosc,et al.  Danger of Systemic Cyclosporine for Corneal Graft , 2002, Cornea.

[16]  R. Lechler,et al.  Pathways of allorecognition: implications for transplantation tolerance. , 2002, Transplant immunology.

[17]  S. Böhringer,et al.  Predicting time on the waiting list for HLA matched corneal grafts. , 2002, Tissue antigens.

[18]  M. Thiel,et al.  Penetration of engineered antibody fragments into the eye , 2002, Clinical and experimental immunology.

[19]  U. Stenevi,et al.  Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register , 2002, The British journal of ophthalmology.

[20]  R. Dana,et al.  Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II–positive Dendritic Cells Derived from MHC Class II–negative Grafts , 2002, The Journal of experimental medicine.

[21]  D. Gartry,et al.  Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study , 2001, The British journal of ophthalmology.

[22]  J. Niederkorn.  Mechanisms of Corneal Graft Rejection: The Sixth Annual Thygeson Lecture, Presented at the Ocular Microbiology and Immunology Group Meeting, October 21, 2000 , 2001, Cornea.

[23]  M. Dana,et al.  Role of CD4+ and CD8+ T Cells in Allorecognition: Lessons from Corneal Transplantation1 , 2001, The Journal of Immunology.

[24]  S. Klebe,et al.  PROLONGATION OF SHEEP CORNEAL ALLOGRAFT SURVIVAL BY EX VIVO TRANSFER OF THE GENE ENCODING INTERLEUKIN-101 , 2001, Transplantation.

[25]  R. Dana,et al.  The critical role of lymph nodes in corneal alloimmunization and graft rejection. , 2001, Investigative ophthalmology & visual science.

[26]  M. Araie,et al.  Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty. , 1999, Japanese journal of ophthalmology.

[27]  J. Niederkorn,et al.  The role of cytotoxic T lymphocytes in corneal allograft rejection. , 2000, Investigative ophthalmology & visual science.

[28]  H. Völker‐Dieben,et al.  BENEFICIAL EFFECT OF HLA-DR MATCHING ON THE SURVIVAL OF CORNEAL ALLOGRAFTS1 , 2000, Transplantation.

[29]  J. Forrester,et al.  Campath-1H therapy in refractory ocular inflammatory disease , 2000, The British journal of ophthalmology.

[30]  J. Pepose,et al.  CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. , 1997, The Journal of clinical investigation.

[31]  S. Gore,et al.  INFLUENCE OF DONOR AND HISTOCOMPATIBILITY FACTORS ON CORNEAL GRAFT OUTCOME , 1994, Transplantation.

[32]  P. Holt,et al.  Immunomorphologic studies of macrophages and MHC class II-positive dendritic cells in the iris and ciliary body of the rat, mouse, and human eye. , 1994, Investigative ophthalmology & visual science.

[33]  N. Nguyen,et al.  Aqueous flare following penetrating keratoplasty and in corneal graft rejection. , 1994, Archives of ophthalmology.

[34]  J. Hill,et al.  Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy. , 1994, Ophthalmology.

[35]  P. Laughrea,et al.  Risk factors of corneal graft failure. , 1993, Ophthalmology.

[36]  M. Jager.  Corneal Langerhans cells and ocular immunology. , 1992, Regional immunology.

[37]  D. Roder,et al.  Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. , 1992, Ophthalmology.

[38]  M. Maguire,et al.  Reproducibility of HLA-A, B, and DR typing using peripheral blood samples: results of retyping in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Group (corrected) , 1992, Human Immunology.

[39]  P. Heering,et al.  Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. A retrospective study. , 1992, German journal of ophthalmology.

[40]  D. Coster,et al.  Leukocytes in the graft bed associated with corneal graft failure. Analysis by immunohistology and actuarial graft survival. , 1989, Ophthalmology.

[41]  A. Bill.  The blood-aqueous barrier. , 1986, Transactions of the ophthalmological societies of the United Kingdom.

[42]  J. Pepose,et al.  Detection of HLA class I and II antigens in rejected human corneal allografts. , 1985, Ophthalmology.

[43]  D. Coster,et al.  HISTOCOMPATIVILITY ANTIGEN AND PASENGER CELL CONTENT OF NORMAL AND DISEASED HUMAN CORNEA , 1985, Transplantation.

[44]  R. D. Stulting,et al.  The distribution of HLA antigens on human corneal tissue. , 1984, Investigative ophthalmology & visual science.

[45]  H. Völker‐Dieben,et al.  THE EFFECT OF PROSPECTIVE HLA‐A AND ‐B MATCHING ON CORNEAL GRAFT SURVIVAL , 1982, Acta ophthalmologica.

[46]  J. D. Salisbury,et al.  Blood group antigens on human corneal cells demonstrated by immunoperoxidase staining. , 1981, American journal of ophthalmology.

[47]  P. Medawar.  Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. , 1948, British journal of experimental pathology.